HTFL Stock Price, Analysis & Fundamentals

Analysis

Heartflow, Inc. is a healthcare company operating within the Health Information Services industry. The company has a significant market presence with a market capitalization of $2.59 billion and revenue of $161.88 million (TTM). Heartflow employs 626 individuals. The company's financial health is marked by negative profitability metrics. Gross margin stands at 75.6%, while operating and profit margins are -32.6% and -77.4%, respectively. The debt-to-equity ratio is 8.56, indicating a significant level of leverage. Heartflow maintains a strong cash position with $291.17 million in cash reserves, offset by a relatively small debt burden of $21.79 million. Heartflow's valuation is characterized by a forward P/E ratio of -58.41 and an EV/EBITDA ratio of -35.50. The company has achieved revenue growth of 40.5% year-over-year. Dividend information is not applicable, with a payout ratio of 0.0%.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Heartflow, Inc.

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.

Visit website →

HTFL

Price History (1Y)

Analysis

About Heartflow, Inc.

Key Statistics

Company Info